Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Astellas Pharma Inc (JP:4503)
TSE/TYO:4503
Astellas Pharma (4503) Stock Price & Analysis
0 Followers
4503 Stock Chart & Stats
Day’s Range¥0 - ¥0
52-Week Range¥1,426.00 - ¥2,187.13
Previous Close¥1,590
Volume8.16M
Average Volume (3M)7.78M
Market Cap
¥2.86T
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)167.3
Beta0.67
Next Earnings
Jul 30, 2024EPS Estimate
¥9.89Last Dividend Ex-Date
Mar 28, 2024Dividend Yield5.07%
Share Statistics
EPS (TTM)7.18
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume7,775,998
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
4.33% Mutual Funds
9.37% Other Institutional Investors
86.31% Public Companies and
Individual Investors
4503 FAQ
What was Astellas Pharma Inc’s price range in the past 12 months?
Astellas Pharma Inc lowest stock price was ¥1426.00 and its highest was ¥2187.13 in the past 12 months.
What is Astellas Pharma Inc’s market cap?
Currently, no data Available
When is Astellas Pharma Inc’s upcoming earnings report date?
Astellas Pharma Inc’s upcoming earnings report date is Jul 30, 2024 which is in 30 days.
How were Astellas Pharma Inc’s earnings last quarter?
Astellas Pharma Inc released its earnings results on Apr 25, 2024. The company reported -¥18.554 earnings per share for the quarter, missing the consensus estimate of -¥2.888 by -¥15.666.
Is Astellas Pharma Inc overvalued?
According to Wall Street analysts Astellas Pharma Inc’s price is currently Overvalued.
Does Astellas Pharma Inc pay dividends?
Astellas Pharma Inc pays a Annually dividend of ¥35 which represents an annual dividend yield of 5.07%. See more information on Astellas Pharma Inc dividends here
What is Astellas Pharma Inc’s EPS estimate?
Astellas Pharma Inc’s EPS estimate is ¥9.89.
How many shares outstanding does Astellas Pharma Inc have?
Astellas Pharma Inc has 1,809,663,100 shares outstanding.
What happened to Astellas Pharma Inc’s price movement after its last earnings report?
Astellas Pharma Inc reported an EPS of -¥18.554 in its last earnings report, missing expectations of -¥2.888. Following the earnings report the stock price went down -0.953%.
Which hedge fund is a major shareholder of Astellas Pharma Inc?
Currently, no hedge funds are holding shares in JP:4503
---
Astellas Pharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-37.89%
12-Months-Change
Fundamentals
Return on Equity
0.96%
Trailing 12-Months
Asset Growth
27.78%
Trailing 12-Months
Company Description
Astellas Pharma Inc
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focus on therapeutic fields that include transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. The firm's global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.
---
4503 Company Deck
---
4503 Earnings Call
Q4 2024
0:00 / 0:00
---
Technical Analysis
Astellas Pharma
―
Takeda Pharmaceutical Company
―
Johnson & Johnson
―
Pfizer
―
GlaxoSmithKline
―
Best Analysts Covering 4503
1 Year
1 Year Success Rate
0/0 ratings generated profit
1 Year Average Return
0.00%
upgraded a buy rating 8 months ago
Copying Unknown Analyst's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
---